Cargando…
Pneumocystis jirovecii Pneumonia Associated with COVID-19 in Patients with Interstitial Pneumonia
Here, we report two cases of patients with interstitial pneumonia (IP) on steroids who developed Pneumocystis jirovecii pneumonia (PJP) following coronavirus disease 2019 (COVID-19) infection. Case 1: A 69-year-old man on 10 mg of prednisolone (PSL) daily for IP developed new pneumonia shortly after...
Autores principales: | Takahashi, Tomoyuki, Saito, Atsushi, Kuronuma, Koji, Nishikiori, Hirotaka, Chiba, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505825/ https://www.ncbi.nlm.nih.gov/pubmed/36143828 http://dx.doi.org/10.3390/medicina58091151 |
Ejemplares similares
-
Acute eosinophilic pneumonia accompanied with COVID‐19: a case report
por: Murao, Koutaro, et al.
Publicado: (2020) -
Dexamethasone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2022) -
Upadacitinib: Pneumocystis jirovecii pneumonia: case report
Publicado: (2021) -
COVID-19 and Pneumocystis jirovecii pneumonia: Back to the basics
por: Mouren, D., et al.
Publicado: (2021) -
Pneumocystis jirovecii pneumonia in developing countries
por: De Armas Rodríguez, Y., et al.
Publicado: (2011)